ASM Conference on Candida and Candidiasis

描述(由申请人提供)： 念珠菌是人类的主要真菌病原体，可引起从口腔和阴道念珠菌病到危及生命的念珠菌症和侵袭性疾病的各种感染。念珠菌领域专注于与流行病学、耐药性、感染、宿主反应和治疗学相关的广泛主题。念珠菌和念珠菌病会议每两年举行一次，是介绍这些不同领域的前沿进展和最新观点的主要论坛。请拨资金为将于2008年3月24日至28日在新泽西州泽西城举行的第九届念珠菌和念珠菌病会议提供部分支助。这次会议由美国微生物学会主办，该学会提供管理专业知识和资金支持。该项目基于该系列以往的会议，可靠地吸引了300多名美国和国际科学家参加，并在参与者调查中得到了热情的支持。我们的节目包括广度和及时性的临床演讲，演讲者经过精心筛选，以确保亲和力和有效性。我们还扩大了抗真菌耐药性、生物被膜和宿主-病原体相互作用的领域，以强调临床上的最新进展。对方案进行了进一步修改，允许根据提交的摘要选择50名发言者，从而灵活地提出前沿进展，并招募新出现的和成熟的社区成员作为发言者。一系列关于药物开发、基因组学和分子技术的并行研讨会将进一步鼓励富有成效的互动和讨论。我们有信心我们的目标--展示这一领域的最新进展、突出初级科学家的成就、促进协同和跨学科互动，以及提供一个供社区广泛讨论的场所--将会实现。念珠菌是引起传染病的主要真菌，影响艾滋病患者、癌症化疗患者、早产儿和许多其他人。第9届念珠菌和念珠菌病会议将为念珠菌研究界提供一个论坛，介绍最新的进展和想法，涵盖从临床问题到分子机制，从真菌的生长到宿主反应的广泛主题。这次会议将有助于规划未来研究的进程，促进了解、治疗和预防疾病的迫切需要。

DESCRIPTION (provided by applicant): Candida is the major fungal pathogen of humans, causing infections that range from oral and vaginal candidiasis to life-threatening candidemia and invasive disease. The Candida field focuses on a broad spectrum of subjects that relate to epidemiology, drug resistance, infection, host response, and therapeutics. The Candida and Candidiasis Conference, held every two years, is the premier forum for presentation of cutting-edge advances and the latest perspectives in these diverse areas. Funds are requested to provide partial support for the 9th Conference on Candida and Candidiasis, which will be held from March 24-28, 2008, in Jersey City, NJ. The conference is sponsored by the American Society for Microbiology, which provides both management expertise and financial support. The program is based upon past conferences of the series, which have reliably drawn attendance of over 300 American and International scientists, and have met with enthusiastic support in participant surveys. Our program includes clinical talks of breadth and timeliness, with speakers carefully prescreened for affability and effectiveness. We have also expanded the areas of antifungal resistance, biofilms, and host-pathogen interaction to emphasize recent advances of clinical relevance. The program has been modified further to permit selection of 50 speakers based on submitted abstracts, providing the flexibility to present cutting-edge advances and to enlist emerging as well as established community members as speakers. A set of concurrent workshops on drug development, genomics, and molecular techniques will further encourage productive interaction and discussion. We are confident that our goals - to present the latest advances in the field, to spotlight achievements of junior scientists, to promote synergistic and interdisciplinary interactions, and to provide a venue for community-wide discussion - will be achieved. Candida is the major fungus that cause infectious disease, affecting AIDS patients, cancer chemotherapy patients, premature infants, and many others. The 9th Conference on Candida and Candidiasis will provide a forum for the Candida research community to present the most recent advances and ideas, covering a broad spectrum of subjects from clinical issues to molecular mechanisms, from growth of the fungus to response of the host. The conference will help chart the course of future research and facilitate the urgent necessity to understand, treat, and prevent disease.